Merus raised €31M in a Series B round in Oct 2013. The company is based in Utrecht, Netherlands. Investors in the round: Life Sciences Partners, Novartis Venture Fund. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €31M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
